Pharmacokinetics of Cannabinoids
Delta-9-tetrahydrocannabinol (Δ-9-THC) is the main psychoactive ingredient of cannabis (marijuana). The present review focuses on the pharmacokinetics of THC, but also includes known information for cannabinol and cannabidiol, as well as the synthetic marketed cannabinoids, dronabinol (synthetic THC...
Saved in:
| Main Author: | Iain J McGilveray |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2005-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2005/242516 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants
by: Cristina Sempio, et al.
Published: (2024-11-01) -
Cannabinoids on the Brain
by: Andrew J. Irving, et al.
Published: (2002-01-01) -
Cannabinoids and Pain
by: J Michael Walker, et al.
Published: (2001-01-01) -
Subacute Toxicity and Pharmacokinetic Evaluation of the Synthetic Cannabinoid 4F-MDMB-BUTINACA in Rats: A Forensic and Toxicological Perspective
by: Elkhatim Hassan Abdelgadir, et al.
Published: (2024-10-01) -
The biosynthesis of the cannabinoids
by: M. Nazir Tahir, et al.
Published: (2021-03-01)